Oncogenic BRAF and p53 Interplay in Melanoma Cells and the Effects of the HDAC Inhibitor ITF2357 (Givinostat)Adriana Celesia, Sonia Emanuele|International Journal of Molecular Sciences|2023Cited by 13
The Histone Deacetylase Inhibitor ITF2357 (Givinostat) Targets Oncogenic BRAF in Melanoma Cells and Promotes a Switch from Pro-Survival Autophagy to ApoptosisAdriana Celesia, Sonia Emanuele|Biomedicines|2022Cited by 11